All data are based on the daily closing price as of November 13, 2026
t
Tanvex BioPharma
6541.TW
0.86 USD
0.01
+1.18%
Overview
Last close
0.86 usd
Market cap
226.61M usd
52 week high
2.12 usd
52 week low
0.82 usd
Target price
1.59 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
11.3242
Price/Book Value
1.4996
Enterprise Value
271.81M usd
EV/Revenue
13.5915
EV/EBITDA
-9.0582
Key financials
Revenue TTM
20.00M usd
Gross Profit TTM
-27.33M usd
EBITDA TTM
-39.48M usd
Earnings per Share
-0.17 usd
Dividend
N/A usd
Total assets
N/A usd
Net debt
N/A usd
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.